Cyberounds Logo
May 19, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Community-acquired MRSA
CME credit is no longer available for this conference.
Daniel Scheurich, M.D., and Keith Woeltje, M.D., Ph.D.

Dr. Scheurich is clinical fellow, Department of Medicine, and Dr. Woeltje is Associate Professor, Infectious Diseases, Washington University School of Medicine, St. Louis, MO.

Within the past 12 months, Drs. Scheurich and Woeltje report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.


Release Date: 04/13/2009
Termination Date: 04/13/2012

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss a shift in etiologic agents in skin and soft tissue infections.
  • Enumerate risk factors for carriage and development of infections caused by CA-MRSA.
  • Describe surgical and pharmacologic methods of treatment of skin and skin structure infections caused by CA-MRSA.
  • List and evaluate methods of eradication of CA-MRSA carriage.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity